CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $11,436 | +530.1% | 1,340 | +168.0% | 0.00% | – |
Q1 2023 | $1,815 | +15025.0% | 500 | -75.3% | 0.00% | – |
Q4 2022 | $12 | -99.9% | 2,023 | -15.7% | 0.00% | – |
Q3 2022 | $9,000 | 0.0% | 2,399 | 0.0% | 0.00% | – |
Q2 2022 | $9,000 | 0.0% | 2,399 | 0.0% | 0.00% | – |
Q1 2022 | $9,000 | – | 2,399 | – | 0.00% | – |
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2019 | $7,000 | +133.3% | 1,324 | +32.4% | 0.00% | – |
Q3 2017 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2017 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |